Skip to main content
. 2022 Feb 24;12(2):32. doi: 10.1038/s41408-022-00629-1

Fig. 2. Analysis of lymphocytes, T cells, and cytokines over time following cilta-cel infusion in patients with and without MNTs in CARTITUDE-1.

Fig. 2

Values are shown for A lymphocyte counts; B absolute CD4+ T-cell counts; C absolute CAR+ T cells; D frequency of CAR+ T cells; E IL-6; and F IFN-γ. CAR chimeric antigen receptor, EOI end of infusion, IFN interferon, IL interleukin, MNT(s) movement and neurocognitive treatment-emergent adverse event(s), NTX neurotoxicity, SE standard error.